BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15731573)

  • 1. Parathyroid carcinoma: an overview.
    DeLellis RA
    Adv Anat Pathol; 2005 Mar; 12(2):53-61. PubMed ID: 15731573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
    Parfitt J; Harris M; Wright JM; Kalamchi S
    J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
    Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
    Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours.
    Howell VM; Haven CJ; Kahnoski K; Khoo SK; Petillo D; Chen J; Fleuren GJ; Robinson BG; Delbridge LW; Philips J; Nelson AE; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh DJ; Morreau H; Teh BT
    J Med Genet; 2003 Sep; 40(9):657-63. PubMed ID: 12960210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.
    Shattuck TM; Välimäki S; Obara T; Gaz RD; Clark OH; Shoback D; Wierman ME; Tojo K; Robbins CM; Carpten JD; Farnebo LO; Larsson C; Arnold A
    N Engl J Med; 2003 Oct; 349(18):1722-9. PubMed ID: 14585940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome.
    Tora R; Welch J; Sun J; Agarwal SK; Bell DA; Merino M; Weinstein LS; Simonds WF; Jha S
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3165-3177. PubMed ID: 37339334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation of the HRPT2 gene in parathyroid carcinoma.
    Hewitt KM; Sharma PK; Samowitz W; Hobbs M
    Ann Otol Rhinol Laryngol; 2007 Dec; 116(12):928-33. PubMed ID: 18217513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation.
    Lee JY; Kim SY; Mo EY; Kim ES; Han JH; Maeng LS; Lee AH; Eun JW; Nam SW; Moon SD
    Int J Oncol; 2014 Aug; 45(2):641-50. PubMed ID: 24889687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors.
    Cetani F; Pardi E; Borsari S; Viacava P; Dipollina G; Cianferotti L; Ambrogini E; Gazzerro E; Colussi G; Berti P; Miccoli P; Pinchera A; Marcocci C
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5583-91. PubMed ID: 15531515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic defects associated with familial and sporadic hyperparathyroidism.
    Hendy GN; Cole DE
    Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis of primary hyperparathyroidism.
    Cetani F; Pardi E; Borsari S; Marcocci C
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
    Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2.
    Pausova Z; Soliman E; Amizuka N; Janicic N; Konrad EM; Arnold A; Goltzman D; Hendy GN
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2711-8. PubMed ID: 8675600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.
    Carpten JD; Robbins CM; Villablanca A; Forsberg L; Presciuttini S; Bailey-Wilson J; Simonds WF; Gillanders EM; Kennedy AM; Chen JD; Agarwal SK; Sood R; Jones MP; Moses TY; Haven C; Petillo D; Leotlela PD; Harding B; Cameron D; Pannett AA; Höög A; Heath H; James-Newton LA; Robinson B; Zarbo RJ; Cavaco BM; Wassif W; Perrier ND; Rosen IB; Kristoffersson U; Turnpenny PD; Farnebo LO; Besser GM; Jackson CE; Morreau H; Trent JM; Thakker RV; Marx SJ; Teh BT; Larsson C; Hobbs MR
    Nat Genet; 2002 Dec; 32(4):676-80. PubMed ID: 12434154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary hyperparathyroidism: a current perspective.
    DeLellis RA; Mazzaglia P; Mangray S
    Arch Pathol Lab Med; 2008 Aug; 132(8):1251-62. PubMed ID: 18684024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HRPT2 gene analysis and the diagnosis of parathyroid carcinoma.
    Cetani F; Pardi E; Banti C; Borsari S; Ambrogini E; Vignali E; Cianferotti L; Viccica G; Pinchera A; Marcocci C
    Expert Rev Endocrinol Metab; 2008 May; 3(3):377-389. PubMed ID: 30754207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors.
    Newey PJ; Bowl MR; Cranston T; Thakker RV
    Hum Mutat; 2010 Mar; 31(3):295-307. PubMed ID: 20052758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid cancer.
    Sharretts JM; Kebebew E; Simonds WF
    Semin Oncol; 2010 Dec; 37(6):580-90. PubMed ID: 21167377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families.
    Teh BT; Farnebo F; Twigg S; Höög A; Kytölä S; Korpi-Hyövälti E; Wong FK; Nordenström J; Grimelius L; Sandelin K; Robinson B; Farnebo LO; Larsson C
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2114-20. PubMed ID: 9626148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperparathyroidism-jaw tumor syndrome: Results of operative management.
    Mehta A; Patel D; Rosenberg A; Boufraqech M; Ellis RJ; Nilubol N; Quezado MM; Marx SJ; Simonds WF; Kebebew E
    Surgery; 2014 Dec; 156(6):1315-24; discussion 1324-5. PubMed ID: 25444225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.